ENTITY
Peptidream Inc

Peptidream Inc (4587 JP)

42
Analysis
Health Care • Japan
PeptiDream Inc. is a biopharmaceutical company that researches and develops peptide therapeutics to improve the life of patients.
more
bearish•Rakus Co Ltd
•27 Jul 2022 20:15

JPX-Nikkei 400 2022 Rebal: Final Pre-Event Phase Strategy Worked. What Next?

The official index changes could be announced on 5th August 2022. Expect some positive and negative surprises. Inclusion/Exclusion events could...

Share
bullish•Softbank Corp
•30 May 2022 19:24

JPX-Nikkei 400 Rebalance 2022: Leaderboard End-May 2022

A look at potential Inclusions and Removals for the JPX-Nikkei 400 Rebalance to come in August 2022 based on trading data as of end-May 2022.

Share
bullish•Softbank Corp
•28 Apr 2022 17:27

JPX-Nikkei 400 Rebalance 2022: Leaderboard End-Apr 2022

A look at the potential Inclusions and Removals for the JPX-Nikkei 400 Rebalance to come in August 2022 based on trading data as of end-April 2022.

Share
bullish•Nippo Corp
•30 Mar 2022 21:29

JPX-Nikkei 400 Rebalance 2022: Leaderboard End-Mar 2022

A look at potential Inclusions and Removals for the JPX-Nikkei 400 Rebalance to come in August 2022 based on trading data as of end-March 2022.

Share
•31 Jan 2022 17:49

JPX-Nikkei 400 Rebalance 2022: Leaderboard End-Jan 2022

A look at potential Inclusions and Removals for the JPX-Nikkei 400 Rebalance to come in August 2022 based on trading data as of end-January 2022.

Share
x